(Report ID: 180005) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,591 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 321 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 180005 | Jul, 31, 2006 | 81 | Male |
List of drugs the patient takes:
Results from eHealthMe: 321 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Retinal Haemorrhage | 24 (7.48%) |
Death: 3 (12.50% of total reports)
Cancer: 0
| Name | Count (% of total reports) |
1 | Apnoea | 2 (8.33%) |
2 | Pancreatic Carcinoma | 2 (8.33%) |
3 | Tachycardia | 2 (8.33%) |
4 | Myocardial Ischaemia | 2 (8.33%) |
5 | Cerebrovascular Accident | 2 (8.33%) |
6 | Blindness Transient | 2 (8.33%) |
7 | Visual Acuity Reduced | 2 (8.33%) |
8 | Sudden Death | 2 (8.33%) |
9 | Chest Pain | 2 (8.33%) |
10 | Choroidal Neovascularisation | 2 (8.33%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Vitamin B12 | 2 |
2 | Amlodipine | 2 |
3 | Alphagan | 2 |
4 | Detrol | 2 |
5 | Lucentis | 2 |
6 | Avastin | 2 |
7 | Timoptic | 2 |
8 | Nexium | 2 |
9 | Atorvastatin Calcium | 1 |
10 | Bimatoprost | 1 |
Death: 8 (2.49% of total reports)
Cancer: 0
| Name | Count (% of total reports) |
1 | Visual Acuity Reduced | 49 (15.26%) |
2 | Eye Pain | 30 (9.35%) |
3 | Endophthalmitis | 29 (9.03%) |
4 | Retinal Haemorrhage | 24 (7.48%) |
5 | Eye Haemorrhage | 18 (5.61%) |
6 | Intraocular Pressure Increased | 18 (5.61%) |
7 | Visual Disturbance | 18 (5.61%) |
8 | Nausea | 17 (5.30%) |
9 | Hypersensitivity | 15 (4.67%) |
10 | Injection Site Pain | 14 (4.36%) |
| Name | Count |
1 | Aspirin | 32 |
2 | Lipitor | 22 |
3 | Synthroid | 17 |
4 | Povidone Iodine | 15 |
5 | Nexium | 14 |
6 | Fosamax | 13 |
7 | Multi-vitamin | 13 |
8 | Furosemide | 11 |
9 | Atenolol | 11 |
10 | Hydrochlorothiazide | 11 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
